概述

  • 产品名称
    Anti-HLA D+DR+DQ抗体[35]
  • 描述
    小鼠单克隆抗体[35] to HLA D+DR+DQ
  • 经测试应用
    适用于: IP, Flow Cyt, IHC-Frmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Tumour fragments created by injecting VLM cells, (syngeneic simian virus 40 (SV40)-transformed cell line) into a BALB/c mouse.

  • 常规说明
    Recommended growth conditions: DMEM 5% FCS

性能

  • 形式
    Liquid
  • 存放说明
    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • 存储溶液
    Preservative: None
    Constituents: PBS
  • Concentration information loading...
  • 纯度
    IgG fraction
  • 克隆
    单克隆
  • 克隆编号
    35
  • 骨髓瘤
    unknown
  • 同种型
    IgG3
  • 轻链类型
    unknown
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab20177 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
IP Use at an assay dependent concentration.
Flow Cyt Use at an assay dependent concentration. ab91537-Mouse monoclonal IgG3, is suitable for use as an isotype control with this antibody.
IHC-Fr Use at an assay dependent concentration.

靶标

文献

This product has been referenced in:
  • Allen CA & Hogg N Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes. Cancer Res 47:2919-23 (1987). Read more (PubMed: 3105871) »

See 1 Publication for this product

客户评价及客户问答

There are currently no Customer reviews or Questions for ab20177.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册